EDGAR Filing Documents for 0000950170-23-014985

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0000950170-23-014985

Filing Date

2023-04-27

Accepted

2023-04-27 06:58:53

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	krtx_defa14a_2023.htm	DEFA14A	18211
2	GRAPHIC	img41733264_0.jpg	GRAPHIC	1217607
3	GRAPHIC	img41733264_1.jpg	GRAPHIC	677897
	Complete submission text file	0000950170-23-014985.txt		2627317

Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110

Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244

Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38958 | Film No.: 23851787
SIC: 2834 Pharmaceutical Preparations